Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This feasibility study will evaluate how well hyperpolarized 13C pyruvate magnetic resonance
imaging (MRI) scan works in predicting tumor aggressiveness in patients with renal tumors.
Hyperpolarized 13C pyruvate is a non-radioactive substance with potential usage in the
diagnostic imaging of tumors. Hyperpolarized 13C pyruvate MRI may help doctors determine
non-invasively whether a kidney tumor is a benign tumor or cancer, and if cancer, how
aggressive it is. This may help doctors and patients with renal tumors in the future to make
better treatment decisions.